On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...